Mobile

Evaluating the biological effects of pre-operative intravenous administration of JX-594 (thymidine kinase-deactivated Vaccinia virus plus GM-CSF) prior to planned surgical resection of locally advance...

Update Il y a 5 ans
Reference: ISRCTN13913966

Evaluating the biological effects of pre-operative intravenous administration of JX-594 (thymidine kinase-deactivated Vaccinia virus plus GM-CSF) prior to planned surgical resection of locally advanced/poor prognosis or metastatic cancers

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

Lay summary under review with external organisation

Inclusion criteria

  • Topic: Cancer; Subtopic: Upper Gastro-Intestinal Cancer, Bladder Cancer, Renal Cancer, Melanoma; Disease: Bladder (advanced), Kidney, Liver, Melanoma

Links